WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$210,871,571
+20.2%
3,706,003
-16.5%
0.81%
+16.5%
Q3 2022$175,403,000
-12.7%
4,436,084
-2.9%
0.69%
-7.0%
Q2 2022$200,942,000
-5.6%
4,566,871
-14.5%
0.74%
+17.1%
Q1 2022$212,955,000
+4.4%
5,339,891
+5.2%
0.64%
+15.4%
Q4 2021$204,012,000
+0.4%
5,073,665
+1.5%
0.55%
-3.8%
Q3 2021$203,266,000
-8.3%
4,996,708
+2.3%
0.57%
-17.7%
Q2 2021$221,714,000
-0.4%
4,882,486
-8.5%
0.70%
-3.5%
Q1 2021$222,519,000
-18.1%
5,337,462
-16.1%
0.72%
-20.3%
Q4 2020$271,736,000
+58.6%
6,362,344
-2.4%
0.90%
+35.5%
Q3 2020$171,359,000
-2.8%
6,520,526
-0.9%
0.67%
-7.0%
Q2 2020$176,373,000
+49.4%
6,578,612
+0.2%
0.72%
+24.9%
Q1 2020$118,079,000
+5.2%
6,563,606
+3.7%
0.58%
+28.6%
Q4 2019$112,258,000
+33.6%
6,331,530
+16.9%
0.45%
+24.5%
Q3 2019$84,002,000
+38.2%
5,415,995
+53.0%
0.36%
+40.8%
Q2 2019$60,799,000
+832.6%
3,538,927
+774.0%
0.26%
+844.4%
Q1 2019$6,519,000404,9240.03%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders